Microbiome and Mucosal Immunity in the Intestinal Tract
- PMID: 39740876
- PMCID: PMC11705094
- DOI: 10.21873/invivo.13801
Microbiome and Mucosal Immunity in the Intestinal Tract
Abstract
The human bowel is exposed to numerous biotic and abiotic external noxious agents. Accordingly, the digestive tract is frequently involved in malfunctions within the organism. Together with the commensal intestinal flora, it regulates the immunological balance between inflammatory defense processes and immune tolerance. Pathological changes in this system often cause chronic inflammatory bowel diseases including Crohn's disease and ulcerative colitis. This review article highlights the complex interaction between commensal microorganisms, the intestinal microbiome, and the intestinal epithelium-localized local immune system. The main functions of the human intestinal microbiome include (i) protection against pathogenic microbial colonization, (ii) maintenance of the barrier function of the intestinal epithelium, (iii) degradation and absorption of nutrients and (iv) active regulation of the intestinal immunity. The local intestinal immune system consists primarily of macrophages, antigen-presenting cells, and natural killer cells. These cells regulate the commensal intestinal microbiome and are in turn regulated by signaling factors of the epithelial cells and the microbiome. Deregulated immune responses play an important role and can lead to both reduced activity of the commensal microbiome and pathologically increased activity of harmful microorganisms. These aspects of chronic inflammatory bowel disease have become the focus of attention in recent years. It is therefore important to consider the immunological-microbial context in both the diagnosis and treatment of inflammatory bowel diseases. A promising holistic approach would include the most comprehensive possible diagnosis of the immune and microbiome status of the patient, both at the time of diagnostics and during therapy.
Keywords: Crohn’s disease; Mucosal immunology; chronic inflammatory bowel disease; inflammatory intestinal diseases; intestinal mucosa; review; ulcerative colitis.
Copyright © 2025, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.
Conflict of interest statement
The Authors declare that they have no competing interests.
Figures

Similar articles
-
Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.Dan Med J. 2015 Jan;62(1):B4973. Dan Med J. 2015. PMID: 25557335 Review.
-
Mucosal immune responses to fungi and the implications for inflammatory bowel disease.Curr Opin Gastroenterol. 2018 Nov;34(6):398-403. doi: 10.1097/MOG.0000000000000483. Curr Opin Gastroenterol. 2018. PMID: 30299290 Review.
-
Commensal microbiome and gastrointestinal mucosal immunity: Harmony and conflict with our closest neighbor.Immun Inflamm Dis. 2024 Jul;12(7):e1316. doi: 10.1002/iid3.1316. Immun Inflamm Dis. 2024. PMID: 39023417 Free PMC article. Review.
-
Human Gut-Associated Natural Killer Cells in Health and Disease.Front Immunol. 2019 May 3;10:961. doi: 10.3389/fimmu.2019.00961. eCollection 2019. Front Immunol. 2019. PMID: 31130953 Free PMC article. Review.
-
Intestinal microbiota in inflammatory bowel disease: friend of foe?World J Gastroenterol. 2011 Feb 7;17(5):557-66. doi: 10.3748/wjg.v17.i5.557. World J Gastroenterol. 2011. PMID: 21350704 Free PMC article.
Cited by
-
Microvascular Damage in the Deep Mucosal Lamina Propria Triggers the Onset of Colitis in Dextran Sulfate Sodium-induced Colitis in Mice.In Vivo. 2025 Jul-Aug;39(4):1864-1878. doi: 10.21873/invivo.13986. In Vivo. 2025. PMID: 40578998 Free PMC article.
-
Gut Microbiome, Neuroinflammation, and Fetal Alcohol Spectrum Disorders: Insights from Rodent Models.Biology (Basel). 2025 May 23;14(6):593. doi: 10.3390/biology14060593. Biology (Basel). 2025. PMID: 40563845 Free PMC article. Review.
-
Polygonatum polysaccharides as gut microbiota modulators: implications for autophagy-dependent PD-L1 clearance in cancer immunotherapy.Front Nutr. 2025 Jun 24;12:1612644. doi: 10.3389/fnut.2025.1612644. eCollection 2025. Front Nutr. 2025. PMID: 40630164 Free PMC article. Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources